Live feed16:05:00·281dPRReleasevia QuantisnowAbivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative ColitisByQuantisnow·Wall Street's wire, on your screen.ABVX· Abivax SAHealth Care
